Last updated at 23 hours ago
Director
DIN: 08197315
Kannu Priya is currently associated with 2 companies in various capacities such as Individual Promoter and Individual Subscriber. They serve as a Director at KMCURE PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08197315.Kannu Priya has previously been associated with 1 company in roles such as Director.Kannu Priya is currently involved in 2 different roles. Their most recent position is with KM HOSPITAL PRIVATE LIMITED as a Individual Subscriber. The first company Kannu Priya was appointed to was KMCURE PHARMACEUTICALS PRIVATE LIMITED. Kannu Priya is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Kannu Priya is currently associated with 2 companies in various capacities such as Individual Promoter and Individual Subscriber. They serve as a Director at KMCURE PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08197315.Kannu Priya has previously been associated with 1 company in roles such as Director.Kannu Priya is currently involved in 2 different roles. Their most recent position is with KM HOSPITAL PRIVATE LIMITED as a Individual Subscriber. The first company Kannu Priya was appointed to was KMCURE PHARMACEUTICALS PRIVATE LIMITED. Kannu Priya is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
1y 4m 8 Months Interval
Company Name | Designation | Date of Appointment |
---|---|---|
KMCURE PHARMACEUTICALS PRIVATE LIMITED | Individual Promoter | 09-Aug-2018 |
KM HOSPITAL PRIVATE LIMITED | Individual Subscriber | 28-Apr-2024 |